Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia
Yoon Seong Kim1, Sung Soo Kim, Jeong Je Cho
1Burke Medical Research Institute, Weill Medical College and Graduate School of Medical Sciences of Cornell University, White Plains, New York 10605, USA.
Abstract:
Microglial activation and inflammation are associated with progressive neuronal apoptosis in neurodegenerative human brain disorders. We sought to investigate molecular signaling mechanisms that govern activation of microglia in apoptotic neuronal degeneration. We report here that the active form of matrix metalloproteinase-3 (MMP-3) was released into the serum-deprived media (SDM) of PC12 cells and other media of apoptotic neuronal cells within 2-6 h of treatment of the cells, and SDM and catalytic domain of recombinant MMP-3 (cMMP-3) activated microglia in primary microglia cultures as well as BV2 cells, a mouse microglia cell line. Both SDM and cMMP-3 induced generation of tumor necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6), IL-1beta, and interleukin-1 receptor antagonist but not IL-12 and inducible nitric oxide synthase, which are readily induced by lipopolysaccharide, in microglia, suggesting that there is a characteristic pattern of microglial cytokine induction by apoptotic neurons. Neither glial cell line-derived neurotrophic factor nor anti-inflammatory cytokines, such as IL-10 and transforming growth factor-beta1, were induced. SDM and cMMP-3 extensively released TNF-alpha from microglia and activated the nuclear factor-kappaB pathway, and these microglial responses were totally abolished by preincubation with an MMP-3 inhibitor, NNGH [N-isobutyl-N-(4-methoxyphenylsulfonyl)-glycylhydroxamic acid]. MMP-3-mediated microglial activation mostly depended on ERK (extracellular signal-regulated kinase) phosphorylation but not much on either JNK (c-Jun N-terminal protein kinase) or p38 activation. Conditioned medium of SDM- or cMMP-3-activated BV2 cells caused apoptosis of PC12 cells. These results strongly suggest that the distinctive signal of neuronal apoptosis is the release of active form of MMP-3 that activates microglia and subsequently exacerbates neuronal degeneration. Therefore, the release of MMP-3 from apoptotic neurons may play a major role in degenerative human brain disorders, such as Parkinson's disease.
Insights
Matrix metalloproteinase-3 (MMP-3) released by dying neurons activates microglia, driving inflammation and further neuronal death. This MMP-3 signaling may worsen neurodegenerative diseases like Parkinson's.
Area of Science:
- Neuroscience
- Molecular Biology
- Immunology
Background:
- Microglial activation and inflammation are hallmarks of neurodegenerative diseases, contributing to neuronal cell death.
- Understanding the molecular triggers for microglial activation in this context is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate the molecular signaling mechanisms by which apoptotic neurons activate microglia.
- To identify specific molecules released by dying neurons that mediate microglial responses.
Main Methods:
- Utilized serum-deprived media (SDM) from apoptotic PC12 cells and recombinant matrix metalloproteinase-3 (MMP-3) to activate primary microglia and BV2 cell lines.
- Analyzed cytokine and chemokine release profiles (e.g., TNF-alpha, IL-6, IL-1beta) using specific assays.
- Investigated intracellular signaling pathways, including NF-kappaB and MAPK pathways (ERK, JNK, p38).
- Assessed the effect of an MMP-3 inhibitor (NNGH) on microglial activation.
- Evaluated the impact of activated microglia on neuronal apoptosis.
Main Results:
- Active MMP-3 was released from apoptotic neuronal cells.
- Both SDM and catalytic domain of recombinant MMP-3 (cMMP-3) activated microglia, inducing specific pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1beta) but not others (IL-12, iNOS).
- MMP-3-induced microglial activation involved the nuclear factor-kappaB pathway and ERK phosphorylation.
- Preincubation with an MMP-3 inhibitor abolished these microglial responses.
- Conditioned media from activated microglia induced further neuronal apoptosis.
Conclusions:
- The release of active MMP-3 from apoptotic neurons serves as a distinct signal that activates microglia.
- MMP-3-mediated microglial activation contributes to a cycle of inflammation and neuronal degeneration.
- MMP-3 signaling represents a potential therapeutic target for neurodegenerative disorders such as Parkinson's disease.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Role of Matrix Metalloproteases in Degradation of ECM
A...
The Extrinsic Apoptotic Pathway
MAPK Signaling Cascades
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Caspases

